unresectable cancer

unresectable cancer

Surgical oncology A malignancy which can't be surgically removed, due either to the number of metastatic foci, or because it is in a surgical danger zone. See Heroic surgery.

Unresectable cancer

A tumor that cannot be completely removed by surgery.
Mentioned in: Neuroblastoma
Mentioned in ?
References in periodicals archive ?
The primary objective of the Phase II clinical trial is to evaluate efficacy of Atiprimod in patients with low to intermediate grade neuroendocrine carcinoma who have metastatic or unresectable cancer and who have progression of their disease despite standard therapy (octreotide).
DC Beadao loaded with irinotecan in patients with unresectable cancer of the
Study design: The study is an open label Phase II study designed to evaluate the anti-tumor efficacy, effect on symptoms, safety and tolerability of Atiprimod over 12 treatment cycles (about 12 months) in patients with low to intermediate grade neuroendocrine carcinoma (also called carcinoid cancer) who have metastatic or unresectable cancer.
The study is an open-label Phase II trial designed to evaluate the anti-tumor efficacy, effect on symptoms, and safety and tolerability of Atiprimod in patients with low to intermediate grade neuroendocrine carcinoma (also called carcinoid cancer) who have metastatic or unresectable cancer and who have progression of their disease despite standard therapy (octreotide and others).
These new strategies of combining complementary treatments now apply not only to patients with unresectable cancers but also to those with resectable disease, for whom, according to current evidence, neoadjuvant and adjuvant chemotherapy improve survival.
The objectives of the study were to evaluate the efficacy, safety and dosimetry of Cotara for the treatment of primary and unresectable cancers of the pancreas, liver, prostate or brain.